未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Human dosimetry of free 211At and meta-[211At]astatobenzylguanidine (211At-MABG) estimated using preclinical biodistribution from normal mice
Ukon, Naoyuki; Zhao, Songji; Washiyama, Kohshin; Oriuchi, Noboru; Tan, Chengbo; Shimoyama, Saki; Aoki, Miho; Kubo, Hitoshi; Takahashi, Kazuhiro; Ito, Hiroshi
分享
收藏
分享
收藏Possibility of cancer-stem-cell-targeted radioimmunotherapy for acute myelogenous leukemia using 211At-CXCR4 monoclonal antibody使用211At-CXCR4单克隆抗体对急性骨髓性白血病进行癌症干细胞靶向放射免疫治疗的可能性
Oriuchi, Noboru; Aoki, Miho; Ukon, Naoyuki; Washiyama, Kohshin; Tan, Chengbo; Shimoyama, Saki; Nishijima, Ken-ichi; Takahashi, Kazuhiro; Ito, Hiroshi; Ikezoe, Takayuki; Zhao, Songji
分享
收藏A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II)
Nishikawa, Kazuhiro; Tsuburaya, Akira; Yoshikawa, Takaki; Kobayashi, Michiya; Kawada, Junji; Fukushima, Ryoji; Matsui, Takanori; Tanabe, Kazuaki; Yamaguchi, Kazuya; Yoshino, Shigefumi; Takahashi, Masazumi; Hirabayashi, Naoki; Sato, Seiji; Nemoto, Hiroshi; Rino, Yasushi; Nakajima, Junta; Aoyama, Toru; Miyagi, Yohei; Oriuchi, Noboru; Yamaguchi, Kensei; Miyashita, Yumi; Morita, Satoshi; Sakamoto, Junichi
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Transport of 3-fluoro-L-α-methyl-tyrosine (FAMT) by organic ion transporters explains renal background in [18F]FAMT positron emission tomography
Wei, Ling; Tominaga, Hideyuki; Ohgaki, Ryuichi; Wiriyasermkul, Pattama; Hagiwara, Kohei; Okuda, Suguru; Kaira, Kyoichi; Kato, Yukio; Oriuchi, Noboru; Nagamori, Shushi; Kanai, Yoshikatsu
分享
收藏Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma
Kaira, Kyoichi; Sunose, Yutaka; Arakawa, Kazuhisa; Sunaga, Noriaki; Shimizu, Kimihiro; Tominaga, Hideyuki; Oriuchi, Noboru; Nagamori, Shushi; Kanai, Yoshikatsu; Oyama, Tetsunari; Takeyoshi, Izumi
分享
收藏Expression of amino acid transporters (LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma
Namikawa, Masashi; Kakizaki, Satoru; Kaira, Kyoichi; Tojima, Hiroki; Yamazaki, Yuichi; Horiguchi, Norio; Sato, Ken; Oriuchi, Noboru; Tominaga, Hideyuki; Sunose, Yutaka; Nagamori, Shushi; Kanai, Yoshikatsu; Oyama, Tetsunari; Takeyoshi, Izumi; Yamada, Masanobu
分享
收藏
分享
收藏ASC AMINO ACID TRANSPORTER 2 (ASCT2) AS A NOVEL PROGNOSTIC MARKER IN NON-SMALL-CELL LUNG CANCER
Shimizu, K.; Kaira, K.; Tomizawa, Y.; Sunaga, N.; Kawashima, O.; Oriuchi, N.; Kana, Y.; Yamada, M.; Oyama, T.; Takeyoshi, I.
分享
收藏Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer
Toyoda, M.; Kaira, K.; Ohshima, Y.; Ishioka, N. S.; Shino, M.; Sakakura, K.; Takayasu, Y.; Takahashi, K.; Tominaga, H.; Oriuchi, N.; Nagamori, S.; Kanai, Y.; Oyama, T.; Chikamatsu, K.
分享
收藏Biological significance of fluorine-18-α-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancer
Suzuki, S.; Kaira, K.; Ohshima, Y.; Ishioka, N. S.; Sohda, M.; Yokobori, T.; Miyazaki, T.; Oriuchi, N.; Tominaga, H.; Kanai, Y.; Tsukamoto, N.; Asao, T.; Tsushima, Y.; Higuchi, T.; Oyama, T.; Kuwano, H.
分享
收藏